Microscopic spread of low rectal cancer in regions of mesorectum: Pathologic assessment with whole-mount sections

Department of Gastroenterology Surgery and Institute of Digestive Surgery, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
World Journal of Gastroenterology (Impact Factor: 2.37). 11/2004; 10(20):2949-53.
Source: PubMed


To assess the microscopic spread of low rectal cancer in mesorectum regions to provide pathological evidence for the necessity of total mesorectal excision (TME).
A total of 62 patients with low rectal cancer underwent low anterior resection and TME, surgical specimens were sliced transversely on the serial embedded blocks at 2.5 mm interval, and stained with hematoxylin and eosin (HE). The mesorectum on whole-mount sections was divided into three regions: outer region of mesorectum (ORM), middle region of mesorectum (MRM) and inner region of mesorectum (IRM). Microscopic metastatic foci were investigated microscopically on the sections for the metastatic mesorectal regions, frequency, types, involvement of lymphatic vessels and correlation with the original rectal cancer.
Microscopic spread of the tumor in mesorectum and ORM was observed in 38.7% (24/62) and 25.8% (16/62) of the patients, respectively. Circumferential resection margin (CRM) with involvement of microscopic metastatic foci occurred in 6.5% (4/62) of the patients, and distal mesorectum (DMR) involved was 6.5% (4/62) with the spread extent within 3 cm of low board of the main lesions. Most (20/24) of the patients with microscopic metastasis in mesorectum were in Dukes C stage.
Results of the present study support that complete excision of the mesorectum without destruction of the ORM is essential for surgical management of low rectal cancer, an optimal DMR clearance resection margin should be no less than 4 cm, further pathologic assessment of the regions in extramesorectum in the pelvis is needed.

Download full-text


Available from: Zhao Wang, Jan 12, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Treatment of rectal cancer requires an interdisciplinary approach, with imaging techniques and morphological examination playing important roles. The pathologist is involved in several steps of diagnostics and treatment planning for patients with rectal tumors. Starting with the preoperative biopsy, the pathologist confirms the diagnosis of cancer and estimates the biological behavior of the tumor by classification and grading. In­traoperative diagnostics ensure the completeness of resection and postoperative examinations provide final histopathological and pTNM-classification. Additionally, information about the therapeutic response to neoadjuvant strategies is provided by the assessment of tumor regression. By including molecular pathological methods, the pathologist can evaluate predictive markers (e.g., KRAS mutation analysis for antibody therapy) and contribute to the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) by analyzing microsatellite instability. This chapter describes the role of pathology in the management of rectal cancer.
    No preview · Article · Jan 2010
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the treatment of rectal cancer, surgery is the principal therapeutic modality for cure. Over time, the surgical treatment of rectal cancer has undergone major developments, with differing pathways in the West and the East. In the West, total mesorectal excision (TME) has become the standard, often combined with neoadjuvant or adjuvant treatment. In the East, initiated by Japanese surgeons, the lateral lymph node dissection (LLND) has become the gold standard in cases of advanced rectal cancer, without the use of (neo)adjuvant treatment regimens. Both surgical treatment approaches and nerve-sparing methods are discussed, including analysis of oncologic outcomes (patterns of local recurrence), major complications rates (including anastomotic leakage), and comparison of Eastern and Western adjuvant treatment modalities, as well as future perspectives in surgical approaches to this disease.
    No preview · Chapter · Jan 1970
  • [Show abstract] [Hide abstract]
    ABSTRACT: A full digital RF field control module (FCM) has been developed for SNS LINAC. The digital hardware for all the control and DSP functionalities, including the final vector modulation as well as IF output synthesis, is implemented on a single high-density FPGA. Two of its HDL models have been written in VHDL and Verilog respectively, and both have being used to support the testing and commissioning of the LINAC to the date. The control algorithm used in the HDL produces a latency as low as 150nS. During the commissioning, the flexibility and capacity for needed precise controls that only digital design can provide has proved to be a necessity for meeting the great challenge of a high-power pulsed SCL.
    No preview · Conference Paper · Jun 2005
Show more